VHL Protein Alterations in Sporadic Renal Cell Carcinoma

Clinical Oncology

Volumn 19, Issue 10, 2007, Pages 784-789

  Gimenez Bachs J M ^a   Salinas Sanchez A S ^a   Sanchez Sanchez F ^b   Lorenzo Romero, J G ^a   Donate Moreno, M J ^a   Pastor Navarro, H ^a   Carrion Lopez P ^a   Escribano Martinez J ^b   Virseda Rodriguez J A ^a  

^a Hospital and University Complex of Albacete   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Mutation; renal cell carcinoma; vhl gene; VHL protein

Indexed keywords

AMINO ACID; VON HIPPEL LINDAU PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; INTRON; KIDNEY CARCINOMA; KIDNEY SARCOMA; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; OBSERVATIONAL STUDY; ONCOCYTOMA; PAPILLARY CARCINOMA; PHYSICAL CHEMISTRY; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CROSS-SECTIONAL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ANALYSIS, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 35548986596     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.08.014     Document Type: Article

References (29)

1. Chicharro Almarza G.J., López García J., Golbano Ablanque J., Otero Tejero I., and Serrano Pascual A. Genética y biología molecular del carcinoma de células renales. In: Resel Estévez L., and Moreno Sierra J. (Eds). Oncología urológica. 1st edn (2003), Grupo Saned, Madrid 287-309
2. Iliopoulos O., and Eng C. Genetic and clinical aspects of familial renal neoplasms. Semin Oncol 27 (2000) 138-149
3. Morita R., Ishikawa J., Tsutsumi M., et al. Allelotype of renal cell carcinoma. Cancer Res 51 (1991) 820-823
4. Crossey P.A., Foster K., Richards F.M., et al. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum Genet 95 (1994) 53-58
5. Béroud C., Joly D., Gallou C., Staroz F., Orfanelli M.T., and Junien C. Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 26 (1997) 256
6. Latif F., Tory K., Gnarra J., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260 (1993) 1317-1320
7. Kondo K., and Kaelin Jr. W.G. The von Hippel-Lindau tumor suppressor gene. Exp Cell Res 264 (2001) 117-125
8. Kaelin W.G., Iliopoulos O., Lonergan K.M., and Ohh M. Functions of the von Hippel-Lindau tumour suppressor protein. J Intern Med 243 (1998) 535-539
9. Richards F.M. Molecular pathology of von Hippel-Lindau disease and the VHL tumour suppressor gene. Exp Rev Mol Med (2001 19 March). http://www.expertreviews.org/01002654h.htm [accesed 18.09.07]
10. Turner K.J., Moore J.W., Jones A., et al. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 62 (2002) 2957-2961
11. McGuffin L.J., Bryson K., and Jones D.T. The PSIPRED protein structure prediction server. Bioinformatics 16 (2000) 404-405
12. Jones D.T. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 292 (1999) 195-202
13. Guinan P., Sobin L.H., Algaba F., et al. TNM staging of renal cell carcinoma. Workgroup no. 3. Union Internationale contre le cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 (1997) 992-993
14. Fleming S. Genetics of renal tumors. Cancer Metastatis Rev 16 (1997) 127-140
15. Linehan W.M., Lerman M.I., and Zbar B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. J Am Med Assoc 273 (1996) 564-570
16. Iliopoulos O., Kibel A., Gray S., and Kaelin W.G. Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1 (1995) 822-826
17. Tsutsumi H., Miyamoto C., Furuichi Y., Yoshiike M., Nozawa S., and Iwamoto T. VHL tumor suppressor gene: its mutation and protein level in renal cell carcinoma. Oncol Rep 10 (2003) 1357-1361
18. Gallou C., Joly D., Méjean A., et al. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum Mutat 13 (1999) 464-475
19. Ma X., Yang K., Lindblad P., Egevad L., and Hemminki K. VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium. Oncogene 20 (2001) 5393-5400
20. Schraml P., Struckman K., Hatz F., et al. VHL mutations and their correlation with tumor cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J Pathol 196 (2002) 186-193
21. Giménez Bachs J.M., Salinas Sánchez A.S., Sánchez Sánchez F., et al. Determination of vhl gene mutations in sporadic renal cell carcinoma. Eur Urol 49 (2006) 1051-1057
22. Gnarra J.R., Tory K., Schimdt L., et al. Mutations of the vhl tumour suppressor gene in renal carcinoma. Nat Genet 7 (1994) 85-90
23. Barnabas N., Amin M.B., Pindolia K., Nanavati R., Amin M.B., and Worsham M.J. Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma. J Surg Oncol 80 (2002) 52-60
24. Giménez Bachs J.M., Salinas Sánchez A.S., Lorenzo Romero J.G., et al. Análisis mutacional del gen vhl en el carcinoma de células renales de aparición esporádica. Arch Esp Urol 57 (2004) 671-677
25. Sufan R.I., Jewett M.A., and Ohh M. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal cell carcinoma. Am J Physiol Renal Physiol 287 (2004) F1-F6
26. Maranchie J.K., and Linehan W.M. Hereditary renal cell carcinoma and the von Hippel-Lindau gene. In: Belldegrun A., Ritchie A.W.S., Figlin R.A., Oliver R.T.D., and Vaughan E.D. (Eds). Renal and adrenal tumors. Biology and management. 1st edn (2003), Oxford University Press, New York 98-108
27. Stebbins C.E., Kaelin W.G., and Pavletich N.P. Structure of the VHL-Elongin C-Elongin B complex: implications for VHL tumor suppressor function. Science 284 (1999) 455-461
28. Doenlson J.E. Regulación de la expresión génica. In: Devlin T.M. (Ed). Bioquímica. 2nd edn (1989), Reverté, Barcelona 969-1020
29. Cotran R.S., Kumar V., and Robbins S.L. Trastornos genéticos. In: Cotran R.S., Kumar V., and Robbins S.L. (Eds). Patología estructural y funcional. 4th edn (1990), McGraw-Hill-Interamericana de España, Madrid 125-168